Intuitive Surgical tops Q3 estimates but discloses $450M antitrust settlement and narrows procedure-growth outlook; shares tumble 6.5% (Oct 21)
What happened
Intuitive Surgical reported third-quarter results that topped analysts' estimates, but the surgical robot maker also disclosed a $450 million antitrust settlement and narrowed its procedure-growth outlook. Shares tumbled 6.5% in premarket trading Wednesday.
Why it matters & what’s next are part of Pro, along with the audio summary.
Start your free 14-day trialWho’s affected & sources
Who’s affected
- Intuitive Surgical (ISRG) — -6.5% premarket; hit by both the settlement disclosure and the narrowed growth outlook. Medical-device/robotics peers — antitrust scrutiny read-through. Healthcare sector — another large-cap medical name repricing growth expectations this season.
Sources